Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramsey Cheung

Showing results (121-130 of 192) with videos related to

Pageof 20
Sort By:
Journal of Clinical and Translational Hepatology|January 1, 2024
Differential Mortality Outcomes in Real-world Patients with Lean, Nonobese, and Obese Nonalcoholic Fatty Liver DiseaseVy H Nguyen, Audrey Ha, Nicholas Ajit Rouillard, et al.
Journal of Viral Hepatitis|July 3, 2025
Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus-Related CirrhosisVicki Wing-Ki Hui, Zeyuan Yang, Terry Cheuk-Fung Yip, et al.
Clinical and Translational Gastroenterology|March 10, 2025
Secondary Spontaneous Bacterial Peritonitis Prophylaxis Is Associated With a Higher Rate of Infections other than Spontaneous Bacterial Peritonitis in 2 US-Based National Cirrhosis CohortsScott Silvey, Nilang Patel, Jacqueline G O'Leary, et al.
Gastro Hep Advances|August 8, 2025
COVID-19 Pandemic-Related Disruptions in Routine Cirrhosis Care and Associated Clinical Outcomes among San Francisco Bay Area VeteransJessica B Rubin, Rebecca Loeb, Alexander Monto, et al.
Clinical and Molecular Hepatology|September 11, 2023
Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world studyVy H Nguyen, Isaac Le, Audrey Ha, et al.
BMC Medicine|August 4, 2020
Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencingHaikun Zhang, Peiling Dong, Shicheng Guo, et al.
Journal of Medical Virology|December 13, 2019
Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disordersMichael Fuchs, Alexander Monto, Norbert Bräu, et al.
JAMA Network Open|November 18, 2024
Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040Sikai Qiu, Jiangying Cai, Zhanpeng Yang, et al.
The American Journal of Gastroenterology|October 19, 2018
Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular CarcinomaJacqueline Estevez, Ju Dong Yang, Jennifer Leong, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by raceXiao-Song He, Xuhuai Ji, Matthew B Hale, et al.
Pageof 20

Showing results (121-130 of 192) with videos related to

Sort By:
Pageof 20
Journal of Clinical and Translational Hepatology|January 1, 2024
Differential Mortality Outcomes in Real-world Patients with Lean, Nonobese, and Obese Nonalcoholic Fatty Liver DiseaseVy H Nguyen, Audrey Ha, Nicholas Ajit Rouillard, et al.
Journal of Viral Hepatitis|July 3, 2025
Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus-Related CirrhosisVicki Wing-Ki Hui, Zeyuan Yang, Terry Cheuk-Fung Yip, et al.
Clinical and Translational Gastroenterology|March 10, 2025
Secondary Spontaneous Bacterial Peritonitis Prophylaxis Is Associated With a Higher Rate of Infections other than Spontaneous Bacterial Peritonitis in 2 US-Based National Cirrhosis CohortsScott Silvey, Nilang Patel, Jacqueline G O'Leary, et al.
Gastro Hep Advances|August 8, 2025
COVID-19 Pandemic-Related Disruptions in Routine Cirrhosis Care and Associated Clinical Outcomes among San Francisco Bay Area VeteransJessica B Rubin, Rebecca Loeb, Alexander Monto, et al.
Clinical and Molecular Hepatology|September 11, 2023
Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world studyVy H Nguyen, Isaac Le, Audrey Ha, et al.
BMC Medicine|August 4, 2020
Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencingHaikun Zhang, Peiling Dong, Shicheng Guo, et al.
Journal of Medical Virology|December 13, 2019
Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disordersMichael Fuchs, Alexander Monto, Norbert Bräu, et al.
JAMA Network Open|November 18, 2024
Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040Sikai Qiu, Jiangying Cai, Zhanpeng Yang, et al.
The American Journal of Gastroenterology|October 19, 2018
Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular CarcinomaJacqueline Estevez, Ju Dong Yang, Jennifer Leong, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by raceXiao-Song He, Xuhuai Ji, Matthew B Hale, et al.
Pageof 20